-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Downgrades Progyny to Neutral, Lowers Price Target to $17

Benzinga·12/02/2024 14:57:18
Listen to the news
JP Morgan analyst Anne Samuel downgrades Progyny (NASDAQ:PGNY) from Overweight to Neutral and lowers the price target from $22 to $17.